Sun Pharmaceutical Industries, a prominent player in the Indian pharmaceutical sector, made a significant announcement on Monday with the launch of its new medication, Fexuprazan, marketed under the brand name Fexuclue. This novel treatment is specifically designed for Erosive Esophagitis, a severe condition that significantly impacts patients’ quality of life. Despite an unmet medical need, the company’s stock saw a slight dip, reflecting investor caution amid a fluctuating market environment.

Shares of Tata Motors have sharply declined following a significant disruption in its operations. The company’s luxury car division, Jaguar Land Rover (JLR), has paused vehicle shipments from its UK facilities to the US in response to new US trade tariffs. The pause in shipments, coupled with the evolving tariff structure, has resulted in an immediate 11.61 percent drop in Tata Motors' stock, hitting a 52-week low of Rs. 542.55 on the Bombay Stock Exchange (BSE). This setback highlights the vulnerability of global businesses facing tariff-induced uncertainties.

Metropolis Healthcare Ltd. has announced the acquisition of Ahujas' Pathology and Imaging Centre (DAPIC) located in Dehradun for Rs. 35.01 crore. This move is part of the company’s broader strategy to enhance its presence in the northern regions of India, particularly in Uttar Pradesh and Uttarakhand. With the acquisition of DAPIC, Metropolis intends to leverage its advanced testing capabilities and brand recognition to drive further growth and innovation in these high-potential markets.

Honda Motor Co. Ltd. is intensifying its efforts to secure the number one position in India's highly competitive two-wheeler market. The company, which has a long history in India through its wholly-owned arm, Honda Motorcycle and Scooter India (HMSI), is now focusing on expanding its footprint with a diverse range of products, including electric vehicles (EVs), scooters, and motorcycles.

India's merchandise exports to the United States are projected to decline by USD 5.76 billion in 2025 due to the imposition of higher tariffs on a wide range of goods. This forecasted drop, attributed to the new 26 percent duties announced by the U.S. on several product categories, is expected to affect India's competitiveness, particularly in sectors such as electronics, seafood, and automobile components. However, some sectors like textiles, pharmaceuticals, and ceramics may see modest growth despite these tariff hikes.

In an effort to strengthen the Official Statistical System, the Ministry of Statistics and Programme Implementation (MoSPI) launched a revamped Microdata portal on Monday. The new portal promises enhanced data accessibility, a user-friendly experience, and the integration of cutting-edge technologies. In collaboration with the World Bank Technology Team, the ministry has implemented a modern, scalable tech stack that ensures enhanced security and responsiveness.

President Droupadi Murmu’s four-day State Visit to Portugal and Slovakia marks a historic occasion, with significant diplomatic and economic implications for India. This visit is the first of its kind in nearly three decades and is happening against the backdrop of changing global trade dynamics, including the recent trade tariffs imposed by the United States.

Berger Paints share price jumped 3.6 percent in early trades on Tuesday as overall markets were trading strong. The recovery in Indian markets has been fueled by recovery in the US markets on Monday after opening lower. Berger Paints is currently looking bullish on technical charts and we could see further momentum in the counter if markets remain stable. Berger Paints (NSE: BERGEPAINT), one of India’s largest decorative paint manufacturers, finds itself navigating a period of volatility with long-term tailwinds intact.

Macrotech Developers Ltd., one of India’s leading real estate companies, reported a strong performance in the fourth quarter of fiscal year 2025, with a 14% increase in sales bookings. The Mumbai-based company posted a record Rs 4,810 crore in sales for the quarter, fueled by sustained demand in the housing sector. This robust growth represents a continuation of the company's upward trajectory, with a total of Rs 17,630 crore in sales bookings for the fiscal year, surpassing its projections.

Emkay Global Financial Services has maintained a bullish stance on Delhivery Ltd, reiterating its BUY recommendation while revising its December 2025 target price to Rs 400, reflecting a 6% downward adjustment. This optimism is fueled by Delhivery’s strategic acquisition of Ecom Express, the second-largest B2C logistics operator in India. The Rs 1,400 crore all-cash deal values Ecom Express at just 0.6x EV/Sales based on FY24 numbers.